Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders.
Journal: Open forum infectious diseases
Published: December 23, 2025
Advances and Controversies in the Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Navigating First-Line Therapies.
Journal: Current hematologic malignancy reports
Published: October 21, 2025
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry.
Journal: Transplantation and cellular therapy
Published: June 10, 2025
Allogeneic Hematopoietic Cell Transplant for B-Cell Lymphomas in the Era of Novel Cellular Therapies: Experience from a Tertiary Canadian Center.
Journal: Current oncology (Toronto, Ont.)
Published: March 24, 2025
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.
Journal: Current oncology (Toronto, Ont.)
Published: September 20, 2024
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients.
Journal: Transplantation and cellular therapy
Published: July 07, 2024
Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD.
Journal: Transplantation and cellular therapy
Published: August 23, 2022
Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Journal: Current oncology (Toronto, Ont.)
Published: July 25, 2022
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
Journal: Transplantation and cellular therapy
Published: July 03, 2022
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.
Journal: Bone marrow transplantation
Published: August 29, 2021
Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.
Journal: European journal of haematology
Published: July 13, 2021
Last Updated: 09/26/2026